Beacon Psychiatric Database Summary
- Unrivaled comprehensive & accurate preclinical and clinical Psychiatric drug and trial data.
- Access to 1,700+ Drugs and 5,200+ Trials, in the Psychiatric space. Commercial deal and company data will be added soon.
- Market leading ontologies, enabling precise navigation of the Psychiatric drug discovery & development landscape
- Manually curated by Psychiatric scientists, with data updated daily
- Your one stop shop for Psychiatric disorder intelligence data
Beacon Psychiatric alongside Beacon Neurology provides a complete, holistic view of the Neuroscience drug development landscape, combining to form our Beacon Neuroscience database solution.
Why Beacon Psychiatric Database?
Advanced Filtering
Drill down into Beacon’s Psychiatric drug and trial data with a unique selection of >30 search filters. Segment the Psychiatric drug and trial landscape to identify the data that matters most to you. Our filters include:
Drug Target
Drug Modality
Disease Indication
Delivery System
Formulation
Target Organ / Cell
Drug Status
How Beacon Psychiatric Database Can Help You?
With the increasing complexity and demand in the Psychiatric field, the chance of successfully progressing your drug to market is less than 7%. It is more crucial than ever to use gold-standard data for every go/no-go decision and adapt to market changes in real time to mitigate risk and provide the best chance of success.
Benchmark your preclinical Psychiatric research with confidence, by accessing preclinical Psychiatric drug discovery and development results data from scientific publications, conference abstracts, posters, investor decks and more. Links to the source material (including conference posters) are included.
Access standardized and manually curated preclinical data including, in vitro and in vivo results, efficacy, toxicity and PK reads-outs.
Secure a strategic advantage by accessing real-time data into 5,200+ Psychiatric clinical trials (from early to late stage). Monitor the competitive landscape with unmatched granularity, with insight into patient selection criteria, trial end point design, drug dosing strategy, toxicity, clinical trial results, and more
Beacon enables users to systematically track developer psychiatric disorder pipelines through advanced search and filtering tools. The platform provides continuously updated data on drug development status, mechanism of action, and clinical trial stage, offering clear visibility into the evolving competitive Psychiatric drug development landscape.
Beacon Psychiatric Database: The Numbers
Beacon Psychiatric Database: Key Data Segments
Drug Data
Revolutionize your searching of the Psychiatric drug development landscape.
Utilize >20 search filters to find programs based on disease indication, drug modality, drug target and many more.
Trial Data
Optimize your Psychiatric clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Psychiatric trial landscape based on drug technologies, combination trials, trial phase, disease indication and more.
Beacon Psychiatric Database Scope
Analyze 1,700+ drugs (preclinical and clinical) and 5,200+ clinical trials (from early to later stage), since 2011.
Beacon Psychiatric covers pharmaceutical interventions for neurological related disorders including:
- Addiction
- Anxiety Disorders
- Depression & Mood Disorders
- Personality Disorders
- Schizophrenia and Psychosis
- Stress & Sleep Disorders
- Eating Disorders
- Psychosexual Disorders
- Neuropsychiatric Developmental Disorders
Beacon Psychiatric also includes a host of preclinical data including, cell line and animal model experimental data.
Key Disease Exclusions:
Traumatic & Structural Neurological Disorders, Peripheral Nervous System Disorders, Autonomic Nervous System Disorders
Who is Beacon Psychiatric Database For?
Beacon Psychiatric is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug and trial data, offering unrivalled insight into the Psychiatric drug development landscape.
Commercial deal and company data will be added to the dataset soon!
Scientific Strategy Leader
Select the right pipeline for your Psychiatric drug development
Research Scientist
Validate new targets & inform your Psychiatric drug design
Clinical Development
Design optimized Psychiatric clinical trials & benchmark against the competition
Business Development
Uncover new Psychiatric drug licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Psychiatric technologies
Translational Development
Confidently take your preclinical Psychiatric drug into the clinic
Related Solutions
Check out additional solutions available from Beacon
Related Resources
Check out Neuroscience related resources available from Beacon
Our Experts
Bruce Morimoto
Neuroscience KOL,
Head of Drug Development,
Fuku Biotech
Eloise Jarvis
Lead Research Analyst,
Beacon Neuroscience
Bertie MacArthur
Divisional Head of Beacon Sales,
Beacon
Hanson Wade Events
Check out the upcoming events from Hanson Wade
